Fig. 5From: Enhanced therapeutic potential of antibody fragment via IEDDA-mediated site-specific albumin conjugationAnti-HER2 ELISA analysis of 4D5scFv-WT, 4D5scFv-G125-HSA, and 4D5scFv-G178-HSA. The purified proteins were loaded to plate initial concentration 250nM to 0.005nM, 4-fold dilution, respectively. Experiments were performed in triplicate, and error bars mean standard deviationsBack to article page